Triazole derivatives with antifungal activity: a pharmacophore model study.
Nowaczyk
Alicja
A
Department of Organic Chemistry, Faculty of Pharmacy, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University, Skłodowskiej-Curie 9, 85-094 Bydgoszcz, Poland. alicja@cm.umk.pl
Modzelewska-Banachiewicz
Bozena
B
D000935:Antifungal Agents / Q000737:chemistry / Q000494:pharmacology*; D001426:Bacterial Proteins / Q000187:drug effects; D003577:Cytochrome P-450 Enzyme System / Q000187:drug effects; D015725:Fluconazole / Q000737:chemistry / Q000494:pharmacology*; D008826:Microbial Sensitivity Tests; D008958:Models, Molecular; D011743:Pyrimidines / Q000737:chemistry / Q000494:pharmacology*; D011799:Quinazolines / Q000737:chemistry / Q000494:pharmacology*; D013329:Structure-Activity Relationship; D014230:Triazoles / Q000737:chemistry / Q000494:pharmacology*; D065819:Voriconazole
D000935:Antifungal Agents; D001426:Bacterial Proteins; D011743:Pyrimidines; D011799:Quinazolines; D014230:Triazoles; D015725:Fluconazole; D003577:Cytochrome P-450 Enzyme System; C501935:cytochrome P-450 CYP51, Mycobacterium tuberculosis; D065819:Voriconazole; C112424:albaconazole